FDA Approves Biohaven’s Nurtec ODT (rimegepant) for Preventative Treatment of Migraine
Nurtec ODT 75 mg is the first oral CGRP antagonist approved to prevent migraine Nurtec ODT 75 mg is now […]
Women who are struggling to get pregnant, beware of false dietary supplements that claim to help cure infertility and other […] ‘We’ve made a lot of mistakes’ on COVID guidance: Dr. Makary Fox News medical contributor Dr. Marty Makary discusses the […] The Biden administration has taken the first step toward ending an emergency exception that allowed hospitals to ration and reuse […] The Food and Drug Administration has lifted in-person dispensing requirements for mifepristone when used for medical termination of early pregnancy. […] The US Food and Drug Administration has declared Medtronic’s recall of seven models of defibrillating cardiac rhythm devices, due to […] HAMILTON, Bermuda, March 18, 2021 (GLOBE NEWSWIRE) — Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (Kiniksa), a biopharmaceutical company with a portfolio […] FDA Approves Zegalogue (dasiglucagon) Injection for the Treatment of Severe Hypoglycemia in People with Diabetes Copenhagen, DK and Boston, MA, […] Videos on social media showing children using insulin delivery pens to self-inject hyaluronic acid has prompted a safety warning from […] (Reuters) – The U.S. Food and Drug Administration (FDA) on Friday approved Bristol-Myers Squibb’s cell-based gene therapy, Breyanzi, to treat […]FDA
FDA warns of bogus fertility claims for some supplements
FDA meeting on COVID-19 vaccines in kids on June 10
FDA: N95 masks, now plentiful, should no longer be reused
FDA Lifts In-Person Dispensing Requirement for Mifepristone
Medtronic Recall of Almost 240,000 ICDs Is Class I, FDA Says
Kiniksa Announces FDA Approval of Arcalyst (rilonacept) for Recurrent Pericarditis
FDA Approves Zegalogue
ASDSA Warns of Rogue Insulin Pen Use for DIY Fillers
FDA approves Bristol-Myers' gene therapy for white blood cell cancer